US Stock MarketDetailed Quotes
SBFM Sunshine Biopharma
- 0.8031
- -0.1269-13.65%
Trading Apr 25 15:56 ET
798.71KMarket Cap-42P/E (TTM)
0.8900High0.7500Low13.68MVolume0.8800Open0.9300Pre Close11.08MTurnover1434.93%Turnover RatioLossP/E (Static)994.53KShares140.000052wk High0.04P/B765.67KFloat Cap0.750052wk Low--Dividend TTM953.39KShs Float6280.0000Historical High--Div YieldTTM15.05%Amplitude0.7500Historical Low0.8090Avg Price1Lot Size
About Sunshine Biopharma Company
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Company Profile
SymbolSBFM
Company NameSunshine Biopharma
Listing DateFeb 15, 2022
Founded2006
CEODr. Steve N. Slilaty, PhD
MarketNASDAQ
Employees44
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1177 Avenue of the Americas,5th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-216-1147
Company Executives
- Name
- Position
- Salary
- Dr. Steve N. Slilaty, PhD
- President, Chief Executive Officer and Chairman of the Board
- 370.00K
- Camille Sebaaly
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 930.00K
- Marc Beaudoin
- Chief Operating Officer
- --
- Malek Chamoun, C.P.A.
- Chief Development Officer
- --
- Dr. Abderrazzak Merzouki, PhD
- Chief Science Officer and Director
- 60.00K
- Dr. Rabi Kiderchah
- Independent Director
- 60.00K
- Dr. Andrew Keller
- Independent Director
- 60.00K
- David Natan
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg